http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109875965-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109875965-B |
| titleOfInvention | Azithromycin dry suspension |
| abstract | The invention discloses a novel azithromycin dry suspension, which has the common defects of poor taste and large gastrointestinal side effect in the prior art. In addition, the azithromycin dry suspension of the American Gilles de la Rayleigh has good dissolution and bioavailability, and the domestic product can not reach the level, so that the innovative process of the invention can reach the bioavailability of the azithromycin dry suspension of the American Gilles de Rayleigh, greatly improve the taste and reduce the gastrointestinal side effect. The prescription of the azithromycin dry suspension is as follows: 100mg of azithromycin, 5-20mg of silicon dioxide, 5-30mg of anhydrous trisodium phosphate, 10-100mg of hydroxypropyl cellulose, 5-20mg of xanthan gum, 4g of cane sugar and a proper amount of essence. Preferably, the prescription further comprises 0.5g of modified tapioca starch. |
| priorityDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.